Enfortumab Vedotin–Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity‐Guided Management

Authors

Institutions

Publication Details

Journal
The Journal of Dermatology
Published
2026-03-26
DOI
https://doi.org/10.1111/1346-8138.70242
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enfortumab Vedotin–Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity‐Guided Management

Riko Yamada, Tomoo Fukuda, Saori Takamura
The Journal of Dermatology
Cutaneous lymphoproliferative disorders research
article

Enfortumab Vedotin–Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity‐Guided Management

Riko Yamada, Tomoo Fukuda, Saori Takamura
article en

Abstract

No abstract available for this paper.
The Journal of Dermatology
Saitama Medical University (JP)
Good health and well-being
Openalex Percentile: Top 5%
Cutaneous lymphoproliferative disorders research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Enfortumab Vedotin–Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity‐Guided Management — Riko Yamada, Tomoo Fukuda, et al. · The Journal of Dermatology (2026) | TGRS Research Map | TGRS